External Beam Radiotherapy News and Research

RSS
External beam radiotherapy otherwise known as teletherapy, is the most frequently used form of radiotherapy. The patient sits or lies on a couch and an external source of radiation is pointed at a particular part of the body. Kilovoltage (also known as, superficial) x-rays are used for treating skin cancer and superficial structures. Megavoltage (or deep) X-rays are used to treat deep-seated tumours (eg bladder, bowel, prostate, lung, brain).
Prostate cancer patients receiving care at MultiD clinic more likely to be advised about treatment choices

Prostate cancer patients receiving care at MultiD clinic more likely to be advised about treatment choices

Clinical trial finds no difference in pain response between SBRT and cEBRT for patients with spinal metastases

Clinical trial finds no difference in pain response between SBRT and cEBRT for patients with spinal metastases

Study proposes new way of concentrating radiotherapy dose in tumors

Study proposes new way of concentrating radiotherapy dose in tumors

World’s first clinical guidance on anal sex after prostate cancer treatments

World’s first clinical guidance on anal sex after prostate cancer treatments

Combination of radiotherapy and anti-hormone treatment can prevent recurrence of hormone-driven breast cancer

Combination of radiotherapy and anti-hormone treatment can prevent recurrence of hormone-driven breast cancer

LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data

LDR brachytherapy for treating early-stage prostate cancer lacks conclusive data

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

Radiation therapy can lower risk of breast cancer recurrence in patients with ‘good risk’ DCIS

Coveted BMJ award bestowed on The Clatterbridge Cancer Center

Coveted BMJ award bestowed on The Clatterbridge Cancer Center

NICE MIB offers SD-IORT using Xoft Axxent electronic brachytherapy system for early stage breast cancer patients

NICE MIB offers SD-IORT using Xoft Axxent electronic brachytherapy system for early stage breast cancer patients

ASTRO clinical practice statement outlines recommendations to customize treatment for rectal cancer

ASTRO clinical practice statement outlines recommendations to customize treatment for rectal cancer

Single dose of intraoperative radiotherapy effective for early stage breast cancer patients

Single dose of intraoperative radiotherapy effective for early stage breast cancer patients

Hitachi receives FDA 510(k) clearance to deliver new PROBEAT-V system to Rochester-based Mayo Clinic

Hitachi receives FDA 510(k) clearance to deliver new PROBEAT-V system to Rochester-based Mayo Clinic

UWE Bristol signs up for latest version of simulated Eclipse Radiotherapy Treatment Planning System

UWE Bristol signs up for latest version of simulated Eclipse Radiotherapy Treatment Planning System

Men who receive brachytherapy more likely to be cancer-free five years later

Men who receive brachytherapy more likely to be cancer-free five years later

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Agenus' Prophage vaccine Phase 2 study hailed in Neuro-Oncology journal

Agenus' Prophage vaccine Phase 2 study hailed in Neuro-Oncology journal

Neuro-Oncology publishes promising phase 2 results from Agenus’ brain cancer vaccine study

Neuro-Oncology publishes promising phase 2 results from Agenus’ brain cancer vaccine study

Targeted radiotherapy could offer viable alternative to current procedures for breast cancer

Targeted radiotherapy could offer viable alternative to current procedures for breast cancer

Proton radiotherapy proves to be cost-effective in treating pediatric brain tumors

Proton radiotherapy proves to be cost-effective in treating pediatric brain tumors

Study: Image-guided brachytherapy prevents growth of cervical tumour in over 90% of patients

Study: Image-guided brachytherapy prevents growth of cervical tumour in over 90% of patients